Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Alosa Health, Boston, MA, USA.
Curr Diab Rep. 2019 Nov 21;19(12):140. doi: 10.1007/s11892-019-1252-0.
Educating clinicians on how to improve the medical management of type 2 diabetes in the modern pharmacologic era represents an enormous challenge given the number of medications available and the diversity across guideline recommendations. Academic detailing uses active social marketing techniques to deliver in-office, face-to-face educational encounters between a trained clinical educator (academic detailer) and a primary care clinician and can improve the quality of prescribing and management decisions, leading to better patient outcomes.
This updated review provides context on how academic detailing programs can improve diabetes-related clinical knowledge and practice among primary care providers, incorporating the perspective of a field-based academic detailer. It also profiles 4 diabetes-specific academic detailing programs varying in geographic scope and detailing approach, based in Massachusetts, Pennsylvania, Vermont, and Saskatchewan Province (Canada). Academic detailing can effectively overcome challenges to increasing the evidence-based use of newer glucose-lowering medications in primary care settings.
综述目的:鉴于可用于治疗 2 型糖尿病的药物数量繁多,且不同指南的推荐存在差异,向临床医生传授如何在现代药理学时代改善 2 型糖尿病的医学管理知识,这是一项巨大的挑战。学术细化采用积极的社会营销技术,在经过培训的临床教育者(学术细化者)和初级保健临床医生之间提供面对面的办公室内教育接触,可改善处方和管理决策的质量,从而改善患者的治疗效果。
最新发现:本综述更新内容提供了关于学术细化项目如何改善初级保健提供者的糖尿病相关临床知识和实践的背景信息,其中纳入了实地学术细化者的观点。它还根据马萨诸塞州、宾夕法尼亚州、佛蒙特州和加拿大萨斯喀彻温省(Saskatchewan Province)的范围和细化方法,介绍了 4 个特定于糖尿病的学术细化项目。学术细化可有效克服在初级保健环境中增加新型降糖药物循证使用的挑战。